Eric Shinohara, MD, MSCI, discusses the future of stereotactic body radiation and surgery in prostate cancer.
Eric Shinohara, MD, MSCI, associate professor and interim chair, Vanderbilt University Medical Center, discusses the future of stereotactic body radiation (SBRT) and surgery in prostate cancer.
For men with limited metastatic disease, radiation therapy can be given beyond the prostate to treat other sites of disease.
However, the role of radiation or surgery may shift according to emerging data exploring these modalities in combination with immunotherapy, explains Shinohara.
Going forward, radiation and surgery may become more widely used for men with a low volume of metastatic disease, concludes Shinohara.